Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Merck
Citi
Johnson and Johnson
Daiichi Sankyo

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 9,439,909

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,439,909
Title:Compositions and methods for sensitizing a neoplastic cell to radiation
Abstract: The invention provides for the use of radiation sensitizing agents in combination with radiation for the treatment of neoplasia, methods for the identification of genotype-specific radiation sensitizing agents, and methods of identifying patients who could benefit from therapy with a genotype-specific radiation sensitizing agent.
Inventor(s): Abazeed; Mohamed (Cleveland, OH), Meyerson; Matthew (Concord, MA), Adams; Drew (Cambridge, MA)
Assignee: The Broad Institute, Inc. (Cambridge, MA) Dana-Farher Cancer Institute, Inc. (Cambridge, MA) President and Fellows of Harvard College (Cambridge, MA)
Application Number:14/466,668
Patent Claims:see list of patent claims

Details for Patent 9,439,909

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up The Broad Institute, Inc. (Cambridge, MA) Dana-Farher Cancer Institute, Inc. (Cambridge, MA) President and Fellows of Harvard College (Cambridge, MA) 2033-08-22 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up The Broad Institute, Inc. (Cambridge, MA) Dana-Farher Cancer Institute, Inc. (Cambridge, MA) President and Fellows of Harvard College (Cambridge, MA) 2033-08-22 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up The Broad Institute, Inc. (Cambridge, MA) Dana-Farher Cancer Institute, Inc. (Cambridge, MA) President and Fellows of Harvard College (Cambridge, MA) 2033-08-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Medtronic
Chinese Patent Office
Baxter
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.